EU Strategy for COVID-19 vaccines

Author (Corporate)
Series Details COM (2020) 245
Publication Date 17/06/2020
Content Type


Communication published by the European Commission on 17 June 2020, setting out a strategy aimed at accelerating the development, manufacturing and deployment of vaccines against COVID-19 (coronavirus).

Further information:

This strategy sets out a joint approach for the European Union (EU) and builds on the mandate received by the Council of the European Union. The Commission vows to support efforts to accelerate the development and availability of safe and effective vaccines in a timeframe between 12 and 18 months, if not earlier. The strategy builds on an earlier step towards joint action, which was taken in the formation of an Inclusive Vaccines Alliance (IVA) by France, Germany, Italy and the Netherlands.

The Strategy has the following objectives:

  • Ensuring the quality, safety and efficacy of vaccines;
  • Securing swift access to vaccines for Member States and their populations while leading the global solidarity effort;
  • Ensuring equitable access to an affordable vaccine as early as possible.

The Strategy rests on the following two pillars: security the production of vaccines in the European Union and sufficient supplies for its Member States through Advance Purchase Agreements with vaccine producers via the Emergency Support Instrument; adapting the EU's regulatory framework to the sanitary emergency and making use of existing regulatory flexibility to accelerate developments, authorisation and availability of vaccines while maintaining standards for quality, safety and efficacy.

The Strategy and related initiatives were subject to debate with the European Parliament's relevant committee on 22 June.

Source Link
Alternative sources
Related Links
Commentary and Analysis
AstraZeneca: Press Release, 13/06/2020: AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

Politico, 03/06/2020: 4 EU states form alliance to negotiate on coronavirus vaccines
EUObserver, 05/06/2020: Commission plans strategy to 'maximise' vaccine access
EUObserver, 12/06/2020: EU wants to pay in advance for promising vaccines, 13/06/2020: Dutch sign up to Oxford University’s Covid-19 vaccine
France24, 13/06/2020: Covid-19: France, Italy, Germany and Netherlands sign vaccine deal for Europe
Euronews, 13/06/2020: Coronavirus vaccine: Europe’s Inclusive Vaccines Alliance strikes giant agreement with AstraZeneca
Reuters, 15/06/2020: AstraZeneca COVID-19 vaccine to be shared across Europe, says France
RFI News, 15/06/2020: France and three other EU countries sign deal for AstraZeneca Covid-19 vaccines
EUObserver, 15/06/2020: EU Commission ready to play bigger role in health sector
EurActiv, 16/06/2020: Coalition of countries aims to keep COVID-19 vaccine manufacturing in Europe
Politico, 16/06/2020: Vaccine alliance casts shadow over Commission’s new strategy
Politico, 17/06/2020: Commission casts itself as world’s vaccine superhero
EurActiv, 18/06/2020: EU goes easy on GMOs in race for COVID-19 vaccine

France: Embassy in London: News, 13/06/2020: Inclusive Vaccines Alliance reaches agreement with AstraZeneca
European Commission: Press Release, 17/06/2020: Coronavirus: Commission unveils EU vaccines strategy
European Commission: News, 17/06/2020: Von der Leyen on European Vaccine Strategy: Making the world safe from the coronavirus
European Parliament: Press Release, 22/06/2020: EU Strategy on COVID-19 vaccines must guarantee safety and accessibility for all

Subject Categories
Subject Tags
International Organisations